Dermatology · Riverside, CA
NPI
1417016544
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
10800 Magnolia Ave
Riverside, CA, 92505
Phone (951) 353-2000
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$322K
1,916 prescriptions
Company payments, 2024
$86.44
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Mary Lien prescribed most often to Medicare patients was Fluorouracil, with 456 prescriptions and refills. In total Mary Lien wrote 1,916 Medicare prescriptions that cost $322K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-02.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Fluorouracil Generic | 456 | 457 | 353 | $17K |
| Calcipotriene Generic | 383 | 390 | 318 | $50K |
| Triamcinolone Acetonide Generic | 144 | 231 | 102 | $6,577 |
| Tacrolimus Generic | 131 | 252 | 83 | $34K |
| Clobetasol Propionate Generic | 112 | 186 | 63 | $4,814 |
| Ketoconazole Generic | 106 | 241 | 65 | $3,160 |
| Mupirocin Generic | 74 | 74 | 44 | $870 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 73 | 123 | 45 | $3,110 |
| Metronidazole Generic | 61 | 76 | 33 | $1,216 |
| Hydrocortisone Generic | 32 | 38 | 28 | $630 |
| Pimecrolimus Generic | 27 | 52 | 15 | $9,852 |
| Doxycycline Monohydrate Generic | 26 | 75 | 15 | $1,475 |
| Retin-A Tretinoin | 23 | 27 | 15 | $717 |
| Otezla Apremilast | 23 | 23 | Under 11 | $102K |
| Imiquimod Generic | 23 | 44 | 11 | $888 |
Brand drugs: 203 claims; generic drugs: 1,713 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Mary Lien $86.44 ($86.44 in general payments such as food, travel and fees) from 2 companies. The largest payer was Pfizer Inc. with $70.44.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 1 | $70.44 |
| LEO Pharma Inc. | 1 | $16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.